Literature DB >> 25487067

Semen quality in men with chronic kidney disease and its correlation with chronic kidney disease stages.

M Lehtihet1, B Hylander2.   

Abstract

The aim of this study was to assess whether chronic kidney disease (CKD) has any impact on semen quality parameters in men with CKD stage 1-5. Results were collected from 66 men with different CKD stages (age 18-50 years). Age and BMI (body mass index) were recorded for each male. Higher CKD stage had a significant negative linear trend on semen volume (P < 0.05), progressive motility (P < 0.01), nonprogressive motility (P < 0.001), sperm concentration (P < 0.01), total sperm number (P < 0.01), cytoplasmic droplets (P < 0.01), teratozoospermia index (P < 0.05) and accessory gland markers, α-glucosidase activity (P < 0.05), zinc (P < 0.01) and fructose (P < 0.01). BMI per se had no significant effect on semen volume, sperm number, sperm concentration, morphology, α-glucosidase activity, fructose concentration or zinc level. A significant negative correlation between BMI and sexual-hormone-binding globulin (SHBG) (P < 0.01) was observed but not with other sex hormones. Age per se was related to a significant decrease of sperm concentration (P < 0.05), normal forms (P < 0.01) and testosterone level (P < 0.05). Our results indicate that CKD stage per se is a factor determining the number of spermatozoa available in the epididymis for ejaculation, in part independent of age-related decrease of testosterone level and BMI.
© 2014 Blackwell Verlag GmbH.

Entities:  

Keywords:  Chronic kidney disease; semen quality; subfertility

Mesh:

Substances:

Year:  2014        PMID: 25487067     DOI: 10.1111/and.12388

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  8 in total

Review 1.  Fertility and reproductive care in chronic kidney disease.

Authors:  Sandra Marie Dumanski; Sofia Bano Ahmed
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

2.  Sexual Function and Testosterone Level in Men With Conservatively Treated Chronic Kidney Disease.

Authors:  Kerstin S Fugl-Meyer; Marie Nilsson; Britta Hylander; Mikael Lehtihet
Journal:  Am J Mens Health       Date:  2017-04-19

Review 3.  Male Sexual Dysfunction and Chronic Kidney Disease.

Authors:  Matthew M Edey
Journal:  Front Med (Lausanne)       Date:  2017-03-22

4.  An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances.

Authors:  Tino Vollmer; Börje Ljungberg; Vera Jankowski; Joachim Jankowski; Griet Glorieux; Bernd G Stegmayr
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

5.  Parenthood and pregnancy in Australians receiving treatment for end-stage kidney disease: protocol of a national study of perinatal and parental outcomes through population record linkage.

Authors:  Erandi Hewawasam; Aarti Gulyani; Christopher E Davies; Elizabeth Sullivan; Sally Wark; Philip A Clayton; Stephen P McDonald; Shilpanjali Jesudason
Journal:  BMJ Open       Date:  2020-05-25       Impact factor: 2.692

Review 6.  Providing Care for Transgender Persons With Kidney Disease: A Narrative Review.

Authors:  David Collister; Nathalie Saad; Emily Christie; Sofia Ahmed
Journal:  Can J Kidney Health Dis       Date:  2021-01-20

Review 7.  Parenthood With Kidney Failure: Answering Questions Patients Ask About Pregnancy.

Authors:  Shilpanjali Jesudason; Amber Williamson; Brooke Huuskes; Erandi Hewawasam
Journal:  Kidney Int Rep       Date:  2022-04-29

8.  Testosterone and gonadotropins but not SHBG vary with CKD stages in young and middle aged men.

Authors:  Britta Hylander; Mikael Lehtihet
Journal:  Basic Clin Androl       Date:  2015-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.